Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chubb
Accenture
Queensland Health
Deloitte
Mallinckrodt
Dow
Healthtrust
AstraZeneca
Merck
Novartis

Generated: October 20, 2017

DrugPatentWatch Database Preview

HIVID Drug Profile

« Back to Dashboard

What is the patent landscape for Hivid, and what generic Hivid alternatives are available?

Hivid is a drug marketed by Roche and is included in one NDA.

The generic ingredient in HIVID is zalcitabine. Additional details are available on the zalcitabine profile page.

Summary for Tradename: HIVID

US Patents:0
Applicants:1
NDAs:1
Bulk Api Vendors: see list76
Clinical Trials: see list4
Patent Applications: see list4,889
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:HIVID at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Roche
HIVID
zalcitabine
TABLET;ORAL020199-001Jun 19, 1992DISCNNoNo► Subscribe► Subscribe► Subscribe
Roche
HIVID
zalcitabine
TABLET;ORAL020199-002Jun 19, 1992DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: HIVID

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Roche
HIVID
zalcitabine
TABLET;ORAL020199-001Jun 19, 1992► Subscribe► Subscribe
Roche
HIVID
zalcitabine
TABLET;ORAL020199-002Jun 19, 1992► Subscribe► Subscribe
Roche
HIVID
zalcitabine
TABLET;ORAL020199-002Jun 19, 1992► Subscribe► Subscribe
Roche
HIVID
zalcitabine
TABLET;ORAL020199-001Jun 19, 1992► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Johnson and Johnson
Boehringer Ingelheim
US Army
Moodys
Accenture
McKinsey
Fish and Richardson
Healthtrust
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot